Clinical Trial Update: Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD) [Phase 2]

View source ↗

Summary

Phase 2 study of Cogane (PYM50028) for early-stage Parkinson's disease (CONFIDENT-PD) has completed. Sponsor Phytopharm conducted the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Cogane

Snippet

Sponsor: Phytopharm | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED